Back to overview
Update Mar 01, 2024

DINAMIQS welcomes new CEO

We are pleased to welcome Martin Kessler as Chief Executive Officer of DINAMIQS.

Martin joins from Rentschler Biopharma SE, where he was Chief Transformation Officer and previously CEO of Rentschler’s US biopharma business and operations. Prior to that, Martin led McKinsey’s medical products operations service line in Europe, working with leading life science companies across strategy, operations and R&D.

Martin’s experience in growing businesses and driving transformations will further help building DINAMIQS into a leading CDMO in the Cell & Gene Therapy space.

To top